Canadian Contraception Consensus Chapter 3 Emergency Contraception

doi:10.1016/s1701-2163(16)39372-0

Cited by 4 publications

(1 citation statement)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, there does appear to be some persistent confusion about the timeframe for use. Although guidance offered by the World Health Organization [ 14 ] and the International Consortium for Emergency Contraception [ 15 ] is clear that LNg-ECPs can be used up to 120 h after unprotected or underprotected sexual intercourse, the labels on LNg-EC products available in Canada still state the timeframe for use is 72 h [ 18 ]. This undoubtedly contributes to a lack of clarity around when LNg-ECPs can be used.…”

Section: Discussionmentioning

confidence: 99%

Exploring the Availability of Emergency Contraception in New Brunswick Pharmacies: A Mystery-Client Telephone Study

Borsella

Foster

2020

Pharmacy

View full text Add to dashboard Cite

Although levonorgestrel-only emergency contraceptive pills (LNg-ECPs) have been available over the counter in Canada for more than a decade, barriers to access persist. We aimed to obtain information about the availability and cost of LNg-ECPs in New Brunswick. Using a mystery-client study design, we called all 207 non-specialty pharmacies in the province posing as a 17-year-old woman seeking something to prevent pregnancy after sex. We evaluated the information provided for accuracy and quality. The overwhelming majority of pharmacies (n = 180, 87%) had at least one brand of LNg-ECPs in stock; the price averaged CAD28.69 (USD21.65). Although the majority of pharmacy representatives provided accurate information about LNg-ECPs, a small number made incorrect statements about the timeframe for use, side effects, and mechanism of action. In nine interactions (4%) pharmacy representatives incorrectly indicated that a male partner could not obtain LNg-ECPs; none indicated that parental involvement was required to procure LNg-ECPs. None of the pharmacy representatives referenced any other modality of emergency contraception, including ulipristal acetate. Our findings suggest that LNg-ECPs are widely available and that most pharmacy representatives are providing accurate medical and regulatory information. However, supporting the continuing education of pharmacists and pharmacy staff, particularly around alternative modalities of emergency contraception, appears warranted.

show abstract

Section: Discussionmentioning

confidence: 99%